Basel
Switzerland
73
2013-07-25
The entities that hold a legal rights for patent applications filed by inventor Novartis AG:
Novartis AG from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
Conjugates comprising an antigen and a carrier molecule
#2 | 2013-07-18Pyrrolopyrimidine compounds and their uses
#3 | 2013-07-18Substituted pyrrolo[2,3-B]pyrazine compounds and their use
#4 | 2013-07-18Maintenance unit for print head
#5 | 2013-07-11Contact lenses containing carotenoid and method for making same
#6 | 2013-07-11Colored contact lenses and method of making the same
#7 | 2013-07-04Polymers
#8 | 2013-07-04SILICONE HYDROGEL MATERIALS WITH CHEMICALLY BOUND WETTING AGENTS
#9 | 2013-07-04TREATMENT OF FIBROSING DISORDERS
#10 | 2013-07-04Heteroaryl compounds and their uses
#11 | 2013-07-045-membered heterocycle-based p38 kinase inhibitors
#12 | 2013-07-04INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
#13 | 2013-07-04USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7
#14 | 2013-07-04IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS
#15 | 2013-07-04Methods of Using IL-1beta Compounds
#16 | 2013-07-04Contact lenses with identifying mark
#17 | 2013-06-27Stabilized and Preserved Ketotifen Ophthalmic Compositions
#18 | 2013-06-27Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
#19 | 2013-06-27Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
#20 | 2013-06-27COMPOSITIONS AND METHODS TO TREAT BONE RELATED DISORDERS
#21 | 2013-06-20New Oral Formulation
#22 | 2013-06-20Methods of treatment and pharmaceutical composition
#23 | 2013-06-20METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITION
#24 | 2013-06-13Adjuvanting meningococcal factor H binding protein
#25 | 2013-06-13ORGANIC COMPOUNDS AND THEIR USES
#26 | 2013-06-13Contact lenses with enzymatically degradable coatings thereon
#27 | 2013-06-13Method of treating a lens forming surface of at least one mold half of a mold for molding ophthalmic lenses
#28 | 2013-06-06Conjugated Vi saccharides
#29 | 2013-05-30Pharmaceutical compositions containing a fluoroquinolone antibiotic drug
#30 | 2013-05-30Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
#31 | 2013-05-30QUATERNISED AMMONIUM CYCLODEXTRIN COMPOUNDS
#32 | 2013-05-30Combination of mirror images to improve signal quality for contact lenses
#33 | 2013-05-23Decreasing potential iatrogenic risks associated with influenza vaccines
#34 | 2013-05-23Dual function fibroblast growth factor 21 proteins
#35 | 2013-05-23Silicone hydrogel lenses with convertible comfort agents
#36 | 2013-05-16RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#37 | 2013-05-16Pyrimidylaminobenzamide derivatives for treatment of neurofibromatosis
#38 | 2013-05-16Decreasing potential iatrogenic risks associated with vaccines and vaccine antigens
#39 | 2013-05-16Dietary fiber composition
#40 | 2013-05-16Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
#41 | 2013-05-16Methods and compositions using FGF23 variant polypeptides with reduced aggregation and cleavage
#42 | 2013-05-16Silicone hydrogel lens with a crosslinked hydrophilic coating
#43 | 2013-05-09Method of treating neurohormonal imbalance
#44 | 2013-05-09PHARMACEUTICAL COMPOSITIONS COMPRISING POLYETHYLENE GLYCOL HAVING A MOLECULAR WEIGHT OF LESS THAN 600 DALTONS
#45 | 2013-05-09Meningococcal fHBP polypeptides
#46 | 2013-05-02TREATMENT OF LIVER DISEASES IN WHICH IRON PLAYS A ROLE IN PATHOGENESIS
#47 | 2013-05-02PHARMACEUTICAL COMPOSITION
#48 | 2013-05-02ORGANIC COMPOUNDS
#49 | 2013-05-02Antagonist antibodies against EphB3
#50 | 2013-05-02Production of ophthalmic devices based on photo-induced step growth polymerization
#51 | 2013-05-02Method for molding an ophthalmic lens
#52 | 2013-04-25Pharmaceutical Formulation of Valsartan
#53 | 2013-04-25Disease-associated proteins
#54 | 2013-04-25PROCESS TO IMPROVE STABILITY OF A PHARMACEUTICAL COMPOSITION
#55 | 2013-04-18Process for preparation of optically active compounds using transfer hydrogenation
#56 | 2013-04-18Substituted aminopropionic derivatives as neprilysin inhibitors
#57 | 2013-04-18Arylsulfonamide based matrix metalloprotease inhibitors
#58 | 2013-04-18Method for making UV-absorbing ophthalmic lenses
#59 | 2013-03-28Pharmaceutical Compositions for the Treatment of Fungal Infections
#60 | 2013-03-21Transplant Rejection Markers
#61 | 2013-03-14Process for preparing biaryl substituted 4-amino butyric acid or derivatives thereof and their use in the production of NEP inhibitors
#62 | 2013-03-14OPHTHALMIC USES OF S1P RECEPTOR MODULATORS
#63 | 2013-03-07Stabilized insulin-like growth factor polypeptides
#64 | 2013-02-21HSP90 INHIBITORS FOR THERAPEUTIC TREATMENT
#65 | 2013-02-14USE OF FIBROBLAST GROWTH FACTOR FRAGMENTS
#66 | 2013-02-14Manufacture process for the preparation of an iron containing phosphate adsorbent
#67 | 2013-02-14Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers
#68 | 2013-02-07Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues
#69 | 2013-02-07Method for making medical devices having antimicrobial coatings thereon
#70 | 2013-02-07UV-absorbers for ophthalmic lens materials
#71 | 2013-01-31Pyrirnidinyl aryl urea derivatives being FGF inhibitors
#72 | 2013-01-31KALLIKREIN 7 MODULATORS
#73 | 2013-01-24Pharmaceutical compositions comprising nilotinib or its salt
54829 ⎘